Global Health
Diplomacy Workshop 2022

Book of Abstracts

Date: 17-18, December
Venue: Zoom Meeting & AP Nishi-Shinjuku
Institute for Global Health Policy Research,
National Center for Global Health and Medicine(NCGM)
MAIL: ighp_event@hosp.ncgm.go.jp

Overview<Purpose>In the 2022 Ministry of Health, Labour and Welfare's Health and Labour Sciences Research
Grant "Study for the Establishment of Strategic and Effective Intervention Methodologies
for International Conferences (20BA1002)," the research team aims to analyze the history
behind current issues in global health, examine global health diplomacy trends of Japanand other nations, establish strategic intervention methodologies for Japan, and develop
an effective global health diplomacy educational program. In addition, the research teamaims to work with the Ministry of Health, Labour and Welfare (MHLW), Ministry of Foreign
Affairs (MOFA), Japan International Cooperation Agency (JICA), and other global healthpolicy organizations and research institutions overseas to develop more realistic andeffective interventions, as well as educational materials and training programs. Amidst thegeopolitical changes caused by the global pandemic of a novel coronavirus disease (COVID19), there is an urgent need to cultivate human resources who can advocate for global
health at the global level in harmony with international and national interests. This
workshop was designed and will be implemented to help achieve such goals.

<Target audience>
The workshop is open to young and mid-level public and private sector practitioners whoare planning to participate in a governing body meeting of international organizations andhave little experience in such international meetings. Possible affiliations include MHLW,
MOFA, JICA, NCGM, universities, think tanks, NGOs, etc.
Expected number of participants: 20 participants and observers (both on arecommendation basis)<Objectives and Goals>
In order to develop human resources who can strategically intervene in the discussion of
global health issues and effectively advocate Japan's position at the World Health
Assembly and other international conferences, the following educational objectives havebeen established
1. Understand governance in international organizations (UN, UN specialized agencies,
partnerships).
2. Understand the pre-conference national coordination and conference preparation
process.
3. Understand the standard rules for international meetings.
4. To be able to speak effectively at international meetings.
5. Acquire techniques for reflecting one's own arguments in international conference
decision-making
6. Nourish an attitude for harmonizing international and national interests
7. Understand the unspoken rules/tactics at international conferences

Global Health Diplomacy Workshop2022

Overview<Date and time>
December 17-18, 2022
<Style>In-person/online lectures and in-person roleplay exercise<Venue>AP Nishi-shinjuku
5F Shinjuku Kifu Building, 7-2-4 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023
Japan<Language>
Sessions with only Japanese instructors will be conducted in Japanese, andsessions involving overseas instructors will be conducted in English.
(Simultaneous interpretation will not be provided.)<Workshop Contents>
1. Overview on global health diplomacy
2. Resolution-making process and effective interventions (interventions,speaking methods)
 How to read the resolution documents
 How to prepare for an effective intervention
i. Examples from Japan and Thailand Practicing Intervention
3. How to take the initiative in negotiations
 Learning from past negotiation cases and personal experiences ofresource persons* As part of the research, we will ask for feedback from the participants toevaluate our curriculum.

3

Global Health Diplomacy Workshop2022

Course Schedule Overview

Day 1, Saturday, 17 December 2022
Time

Session Tittle

Speakers

8:50-9:00

Sign-in on zoom online

9:00-9:30

Self-introduction and course objectives

Prof. Hiroyasu Iso (Japan)

9:30-10:15*World Health Organization and its role in global
health governance (lecture)*Q&A in JapaneseProf. Hiroki Nakatani (Japan)

10:15-10:30 Break*Forming a national position: Japan'scase (lecture)
10:30-11:10 *Q&A in Japanese*Intervention: dos and don’ts*Q&A in Japanese

Dr. Takashi Suzuki (Japan)

Dr. Haruka Sakamoto (Japan)*Recent trends and challenges in access to
medicines and other health products in global
11:10-11:50
health (lecture)*Q&A in Japanese

Dr. Daisuke Koga (Japan)

11:50-13:00 Lunch
13:00-13:15 Briefing on role-play sessions

Dr. Tamami Umeda

13:15-14:15 Team deliberation (60 min)Group facilitators

14:15-14:45 *Mock-up Session (Plenary #1) (30 min)Chair: Prof. Hiroki Nakatani
Feedback from resource persons

14:45-15:15

Break for team deliberation and bilateralmeetings as necessary (30 min)Group facilitators

15:15-17:00*Mock-up Session (Working Group #1)
Break during the session (10 min)Chair Country: TBD
Feedback from resource persons*Sessions online by zoom
Red=Lectures in English; Purple = Roleplay sessions in English (Japanese language may be used occasionally)

4

Global Health Diplomacy Workshop2022

Course Schedule Overview

Day 2, Sunday, 18 December 2022
Time

Session Tittle

Speakers

9:30-9:40

Recap of Day 1

Dr. Eiko Saito

9:40-10:20*G7 taskforce on 100 days mission to respondto future pandemic threats (lecture)*Q&A in Japanese

Dr. Osamu Kunii (GHIT, Japan)

10:20-10:30 Break*Introduction to negotiations (lecture)
10:30-11:30*Q&A in English

Prof. Suwit Wibulpolprasert
Mr. Charlie GarnjanaGoonchorn (Thailand)

11:30-11:40 Break*Real-life negotiations: Case studies of difficult
11:40-12:20 negotiations (lecture)*Q&A in Japanese/English

Dr. Satoshi Ezoe (Japan)

12:20-13:30 Lunch
13:30-14:40 Team deliberation

Group facilitators

14:40-15:00 Break
15:00-15:45 *Mock-up Session (Working Group #2)

Chair Country: TBD
Feedback from resource persons

15:45-16:00 Break
16:00-16:45 *Mock-up Session (Plenary #2)

Chair: Prof. Hiroki Nakatani
Feedback from resource persons

Wrap-up
16:45-17:00 Feedback Survey
Closing Remarks

Wrap-up (Dr. Umeda)
Feedback Survey (Dr. Saito)
Closing (Prof. Iso)

*Sessions online by zoom
Red=Lectures in English; Purple = Roleplay sessions in English (Japanese language may be used occasionally)

5

Global Health Diplomacy Workshop2022

Speakers and Resource persons’ list
Dr. Takashi Suzuki（Japan）
Senior Coordinator for Global Health, International Affairs Division, Minister’s Secretariat, Ministry of
Health, Labour and Welfare, Japan

Dr. Daisuke Koga（Japan）
Division Director, Division of Planning and Management, Office of International Programs, Pharmaceuticals
and Medical Devices Agency

Dr. Osamu Kunii（Japan）
CEO, Global Health Innovative Technology Fund

Dr. Suwit Wibulpolprasert（Thailand）

Vice Chair, International Health Policy Program Foundation (IHPF), Health Intervention and Technology
Assessment Foundation (HITAF), International Health Policy Program (IHPP Thailand), Ministry of Public
Health, Thailand

Mr. Charlie Garnjana-Goonchorn（Thailand）

Deputy Consul-General, Royal Thai Consulate-General, Sydney

Dr. Satoshi Ezoe（Japan）

Director, Global Health Strategy Division, Ministry of Foreign Affairs, Japan

Prof. Kazuaki Miyagishima（France）
Visiting Professor, Institute of Tropical Medicine, Nagasaki University, Japan

Prof. Hiroyasu Iso（Japan）

Director, Institute for Global Health Policy Research (iGHP), National Center for Global Health and Medicine(NCGM)

Prof. Hiroki Nakatani（Japan）

Director, Human Resource Strategy Center for Global Health (HRC-GH), NCGM

Dr. Tamami Umeda（Japan）
Visiting researcher, iGHP, NCGM

Dr. Yuta Yokobori（Japan）
Assistant Director, Division of Partnership Development, Department of Global Network and Partnership,
Bureau of International Health Cooperation, NCGM

Dr. Haruka Sakamoto（Japan）
Associate professor, Section of Global Health, Department of Hygiene and Public Health,Tokyo Women`s Medical University

Dr. Mariko Hosozawa（Japan）
Senior Researcher, Department of Global Health Metrics and Evaluation, iGHP, NCGM

Dr. Eiko Saito（Japan）

Senior Research Fellow, iGHP, NCGM
*NCGM Secretariats will also participate to assist the operation during the workshop.

6

Global Health Diplomacy Workshop2022

Resource person profile

Dr.Takashi SUZUKI

7

Title

MD, MSC

Affiliation

International Affairs Division, Minister’s Secretariat, Ministry of Health, Labour andWelfareProfileTakashi SUZUKI, MD, MSc is Senior Coordinator for Global Health of the Ministry of
Health, Labour and Welfare (MHLW), Japan. He has more than 10 years of experience as
public officer and experienced 4 Japanese ministries including Ministry of Defense(MOD), Ministry of Environment (MOE), and Ministry of Education, Culture, Sports andTechnology (MEXT). Currently He has been working on global health affairs, including
coordination between the Japanese government and the WHO, other international
agencies and countries. He received his BA from Keio University, MD from Kanazawa
University and MSc from The University of Tokyo.

Lecturesummary

The lecture aims to understand Japan’s preparation process for the WHO’s governing
body meetings and gain practical skills to make an effective intervention at thesemeetings.

Reading list

1. WHA 75 Documents Website https://apps.who.int/gb/e/e_wha75.html
2. EB 152 Documents Website https://apps.who.int/gb/e/e_eb152.html
3. WPR RCM https://www.who.int/westernpacific/about/governance/regionalcommittee/session-73/documents
4. WHO Basic Documents https://apps.who.int/gb/bd/

Global Health Diplomacy Workshop2022

Resource person profile

Dr.Daisuke Koga

8

Title

Division Director, Division of Planning and Management, Office of International Programs

Affiliation

Pharmaceuticals and Medical Devices Agency (PMDA)

ProfileMr. Daisuke Koga is Division Director, Division of Planning and Management, Division ofRegulatory Cooperation and Division of Asia II, Office of International Programs,
Pharmaceuticals and Medical Devices Agency (PMDA) of Japan.
He started his career at the Ministry of Health and Welfare of Japan in 1996. He worked in
the area of drugs, medical devices, food additives and controlled substances, and for thecoordination of the research grant by the Ministry. From 2007 to 2010, he worked as
Coordination Officer for review and premarket authorization of new drugs and vaccines at
Division of Evaluation and Licensing in Pharmaceutical and Food Safety Bureau. From 2011
to 2014, he served as Technical Officer at WHO HQ in Geneva for the WHO Programme forInternational Drug Monitoring. After coming back to Japan, he served as a Deputy Director
at the office of Global Health Cooperation, International Affairs Division, MHLW until
March 2020.

Lecturesummary

Health products play critical role in health care system and therefore access to medicinesand other health products has long been discussed in WHA and other global fora as one of
key global health agenda. The session: “Recent trends and challenges in access to
medicines and other health products in global health” is focusing on the resolution
WHA72.8 (2019) entitled “Improving the transparency of markets for medicines, vaccines,
and other health products” and introduces discussions around access to health products in
WHA.

Reading list

1. WHO: Resolution WHA72.8 (2019)https://apps.who.int/gb/ebwha/pdf_files/WHA72/A72_R8-en.pdf
2. NCGM国際医療協力局：決議WHA72.8日本語仮訳
p.33-35, 第72回世界保健総会 決議／決定文（日本語仮訳）
https://kyokuhp.ncgm.go.jp/library/who/2019/WHA72.pdf

Global Health Diplomacy Workshop2022

Resource person profile

Dr.Osamu Kunii

Title

CEO

Affiliation

Global Health Innovative Technology FundProfileDr. Osamu Kunii, MD, Ph.D., MPH, is currently serving as CEO and Executive Director of the
Global Health Innovative Technology Fund (GHIT), which promotes R&D of therapeutics,
diagnostics and vaccines against infectious diseases such as neglected tropical diseases,
tuberculosis and malaria. In the past 30 years he has been engaged in global health,especially infectious diseases control, humanitarian emergencies, maternal and childhealth, health diplomacy, and health policy/strategy development through the Global Fund,
UNICEF, academia, Japanese Ministry of Foreign Affairs and other institutions.
He is currently appointed as Chair of the Working Group of “100 Days Mission Plus” under
the Global Health Taskforce to G7 Summit to be hosted by Japan in 2023.

Lecturesummary

The 2021 G7 Summit in UK agreed on the ambitious mission called “100 Days Mission” tohave safe and effective vaccines, therapeutics and diagnostics within 100 days of a future
pandemic started.
As Japan hosts the next G7 Summit in 2023, Professor Keizo Takemi, Member of the Houseof Councillors initiated the Global Health Taskforce for Hiroshima G7 Summit to present
recommendations to the Japanese government on global health. As the vice chair of theTaskforce and the Chair of the 100 Days Mission Working Group, the speaker will talk onwhether this mission is achievable, what are bottlenecks, how to overcome them, andwhat are Japan’s roles.

Reading list

1.
2.
3.

9

.UK Govwernment. Policy paper Joint statement on delivering the 100
Days Mission https://www.gov.uk/government/publications/jointstatement-on-delivering-the-100-days-mission
CEPI 100 Day Mission https://100days.cepi.net/
Bill Gates. No More Pandemics. May 2022
https://www.gatesnotes.com/How-to-Prevent-the-Next-Pandemic

Global Health Diplomacy Workshop2022

Resource person profile

Dr. Suwit Wibulpolprasert

Affiliation

International Health Policy Program, Bangkok

ProfileDr. Suwit Wibulpolprasert is a public health specialist, administrator and policy advocate at national and global
level. He began his career as a Director and practitioner in rural areas and has various technical and administrative
experience in Thai FDA, the Bureau of Health Policy and Plan, Deputy Permanent Secretary and the senior expert
in Disease Control.
He has been proactively working in public health area more than 3 decades from the grass root to the highest
policy level. In parallel with working for the development of health in country, he is one of global health leader
who is well-known in the public eye as the fore front fighter to protect the benefit of the poors. At present, he is
the Board Member of the National Health Security Office, the National Electronics and Computer Technology
Center, and the National Nanotechnology Centre, the member of the National Science and Technology
development committee.
Dr. Suwit is also the Vice Chair of the International Health Policy Program Foundation (IHPF) and the HealthIntervention and Technology Assessment Foundation (HITAF), the chair of the Yothi Medical Innovation District,
the Chair of the Institute for the Development of Human Research Protections Foundation (IHRPF), and the Chairof the Health and Society Creation Foundation.
Dr. Suwit is one of the most experienced health system specialist and has involved and contributed in Thailand’s
health system development for decades. He always reiterates that health systems can become more equitable,
inclusive and fair through primary health care strengthening. Clear evidences from many developed countries tellus that we are now in the right direction to focus on primary health care, not the institutional care. The success is
not all about money but the most important is the heart and the spirit of the health personnel.

Lecturesummary

Dr. Suwit associates the session with Dr. Attaya Limwattanayingyong.
The session will start with current role of Thailand in global health. (in various platforms and issues) How Thailand
come thus far? (as a global health leader)In this part, we will reveal the landscape of the health sector players and health system in Thailand. How thedomestic health system successfully developed in parallel with our investment in global health capacity building.
To build up and strengthen GH capacities, we use INNE model. (Individual/Node/Network/Environment)
We continue strengthening GH capacity of public health practitioners, inter-sectoral partners and members of civilsociety and private sectors by using WHO governing bodies, and other GH forum, as real-life practising platforms.
We have been engaged in global policy formulation and practising negotiations in all GH forums. Furthermore we
realise the importance of long term sustainability of the GH development, we institutionalize and establish GH
network among MOPH, universities, PH agencies and other sectors (MFA, MOC)

Reading list

1.
2.
3.

10

UNDP. (1997). Capacity Development. New York: UNDP.
Limwattanayingyong A, Thailand and its Development of Global Health System. In: Rojanapithayakorn W,
editors. Thailand Health Profile.2016-2017. Bangkok: Sangchan Publishing; 2017. p. 269-298.
Tiantong S, Limwattanayingyong A, Wibulpolprasert S, Vedrasco L, Kertesz D. Towards optimal collaboration:
reforming the WHO country cooperation strategy in Thailand. Bull World Health Organ 2019;97:642–644.

Global Health Diplomacy Workshop2022

Resource person profile

Mr.Charlie GARNJANA-GOONCHORN

Title

Mr.

Affiliation

Ministry of Foreign Affairs of Thailand

ProfileDr. Charlie Garnjana-Goonchorn joined the Ministry of Foreign Affairs in 2007. He started
his career working at the Treaty Division overseeing various aspects of Thailand’s treaty
making process. During his post at the Permanent Mission of Thailand to the UN in Geneva,
he was in charge of extensive areas of work, including those within the purview of WHO
and UNCTAD. After returning to Thailand in 2017, he has played a key role in several
international disputes involving the Royal Thai Government, in addition to providing legal
advice related to international trade, investment treaties, dispute settlement mechanisms
and arbitration.

Lecturesummary

The lecture will run through the basic principles of negotiation, explore how to use
negotiation skills in a multilateral context especially in Global Health Diplomacy. The
lecture will also highlight what negotiators should be looking out for, what are the usual
traps, and how to address them.

Reading list

11

Global Health Diplomacy Workshop2022

Resource person profile

Dr. Satoshi Ezoe

12

Title

Director, Global Health Strategy Division

Affiliation

Ministry of Foreign Affairs, Government of Japan

ProfileDr. Satoshi Ezoe currently serves as Director, Global Health Strategy Division, International Cooperation
Bureau, Ministry of Foreign Affairs (MOFA), since 2020, where he oversees and coordinates Japan’s global
health diplomacy and strategy, including COVID-19 response. He is also cross appointed as Director at
Headquarters for Healthcare Policy, Cabinet Secretariat, since 2021. Prior to joining MOFA, he was engaged
in health care and public health policy in the Ministry of Health, Labour and Welfare of Japan, including in theareas of global health, universal health insurance system, non-communicable diseases including mental
health and cancer control. He was seconded to UNAIDS Headquarters in Geneva (2009-2012). He was the first
appointed Senior Coordinator for Global Health (2015- 2017), where he was involved in the WHO emergency
reform, coordinating health agendas for the G7 Ise-Shima Summit in 2016. He was most recently Counsellorof the Permanent Mission of Japan to the United Nations (2017-2020), where he was instrumental in
facilitating UN General Assembly High-Level Meetings on tuberculosis (2018) and universal health coverage(2019). He is a Medical Doctor with PhD, and received Master of Public Health and Master in Public
Administration from the Harvard University.

LecturesummaryThis lecture intends to share examples of key and difficult negotiations on global health based on hand-on
experience by the presenter. These cases would include but not limited to below:
1. On 23 September 2019, world leaders at the United Nations (UN) General Assembly High-Level Meetingon Universal Health Coverage unanimously approved the Political Declaration of the High-Level Meetingon Universal Health Coverage, described by UN Secretary-General António Guterres as “the mostcomprehensive agreement ever reached on global health”. This historic agreement reiterates a numberof key principles, including the importance of health for implementation of all the goals and targets ofthe 2030 Agenda for Sustainable Development. World leaders recommitted themselves to achieving
universal health coverage by 2030 and to scaling up global efforts to build a healthier world for all. The
high-level meeting and its political declaration were the result of a series of concerted multi-stakeholder
efforts.
2. Also, the COVAX AMC Summit co-hosted by the Government of Japan and Gavi on June 2nd 2021 might
be touched upon. Prime Minister Suga Yoshihide co-chaired the meeting with Mr. José Manuel Barroso,
Gavi Board Chair, and Foreign Minister Motegi Toshimitsu took the role of facilitator during the Summit.
This Summit was organized to raise additional funding to secure necessary vaccines for developing
countries by the end of 2021, in order to ensure through the COVAX Facility equitable access to safe,
effective and quality-assured vaccines thereby overcoming the COVID-19 pandemic.

Reading list

Essential:
1. Satoshi Ezoe, et.al. (2021) “The Political Declaration of the High-Level Meeting on Universal Health
Coverage (2019): Negotiating the most comprehensive agreement ever reached on global health”, A
GUIDE TO GLOBAL HEALTH DIPLOMACY, Graduate Institute of International and Development Studies.
(PP. 235-252) https://www.graduateinstitute.ch/sites/internet/files/2021-02/GHC-Guide.pdf
2. Prime Minister Shinzo Abe’s participation in the UN High-Level Meeting on Universal Health Coverage(UHC)
English: https://www.mofa.go.jp/ic/ghp/page6e_000218.html
Japanese: https://www.mofa.go.jp/mofaj/ic/ghp/page4_005303.html

Global Health Diplomacy Workshop2022

Resource person profile
Reading list

3.

Outcome of the COVAX AMC Summit. MOFA. June 3, 2021
English: https://www.mofa.go.jp/ic/ghp/page1e_000326.html
Japanese: https://www.mofa.go.jp/mofaj/page1_000979.html

4.

Dr. EZOE Satoshi. “Toward New Solidarity in Global Health: Universal Health Coverage and Reform at theWHO” No.67, Diplomacy Oct. 27, 2021
https://www.japanpolicyforum.jp/pdf/2021/no67/DJweb_67_dip_02.pdf
Japanese: 江副聡（2021） 「国際保健をめぐる新たな連帯へ－ユニバーサル・ヘルス・
カバレッジとWHO改革」 『雑誌 外交』 Vol.65 Jan./Feb. 2021
http://www.gaiko-web.jp/test/wp-content/uploads/2021/01/Vol65_p100105_New_solidarity_over_international_health.pdf
Japanese: 馬渕俊介、江副聡（2021）「「パニック&ネグレクト」 を繰り返すな ―ワクチンへの公平なアクセスに向けた国際的展開」 『雑誌 外交』 Vol.69 Sep./Oct. 2021
http://www.gaiko-web.jp/test/wp-content/uploads/2021/09/Vol69_p110117_Do_not_repeat_Panic_and_neglect.pdf
5.

Key Resources
Cabinet Secretariat. The Global Health Strategy. May 24, 2022 (English/Japanese)
https://www.kantei.go.jp/jp/singi/kenkouiryou/en/pdf/final_GHS_outline.pdf
https://www.kantei.go.jp/jp/singi/kenkouiryou/senryaku/r040524global_health.pdf
UNGA HLM on UHC:
https://www.un.org/pga/73/event/universal-health-coverage/
https://www.uhc2030.org/un-hlm-2019/
Political declaration of the high-level meeting on universal health coverage, Universal health coverage:
moving together to build a healthier world
English: https://undocs.org/en/A/RES/74/2
Japanese: http://kyokuhp.ncgm.go.jp/topics/2020/UN_UHC_J_2020925.pdf
COVAX AMC Summit:
Recording of the Summit
https://www.gavi.org/gavi-covax-amc-summit-2021
Summary:
https://www.gavi.org/vaccineswork/world-leaders-and-private-sector-commit-protecting-vulnerable-covid19-vaccines
Recommended:
1. Address by Prime Minister Kishida at the Seventy-Seventh Session of the United Nations General
Assembly. MOFA. September 20, 2022
English: https://www.mofa.go.jp/fp/unp_a/page3e_001242.html
Japanese: https://www.mofa.go.jp/mofaj/fp/unp_a/page3_003441.html
2.

H. Sakamoto, S. Abe, S. Ezoe. Abe’s legacy – Japan’s contribution to global health. October 30, 2020, BMJ
GH Blogs
https://blogs.bmj.com/bmjgh/2020/10/30/abes-legacy-japans-contribution-to-global-health/3.

Abe S. Japan's vision for a peaceful and healthier world. Lancet. 2015 Dec 12;386(10011):2367-9(English/Japanese) https://www.mofa.go.jp/ic/ghp/page18e_000126.html

4.

Kotono Hara, Satoshi Ezoe. Why does global health matter to diplomacy? Global Health Governance, Vol.
XIII, No. 1 (SPRING 2019)http://blogs.shu.edu/ghg/files/2019/11/Spring-Fall-2019-Issue.pdf#page=23

As available:
江副聡（2020） 「６章 UHC主流化に向けた国際動向と日本の取組み」、城山英明編
ル保健ガバナンス』 東信堂『グローバ

江副聡（2022）「4章１.グローバルヘルス外交」、日本国際保健医療学会編『実践グローバルヘルス－現場における実践力向上をめざして－』杏林書店

13

Global Health Diplomacy Workshop2022

Resource person profile

Prof.Hiroki Nakatani

14

Title

Visiting Professor

Affiliation

Keio University Faculty of Medicine

ProfileIn the past seven years, Dr. Hiroki Nakatani has held academic positions in Japan as Visiting Professor of Keio
University and Invited Professor at Osaka University Post Graduate School of Medicine. He is the former Chairof the Executive Board, WHO. Currently, Dr.Nakatani also serves in various national and internationalorganizations as Adviser (International Affairs) to the Minister of Health, Labour and Welfare; Chair, Board of
Directors, Global Health Innovative Technology Fund (GHIT Fund); Senior-Advisor, Economic Research Institutefor ASEAN and East Asia（ERIA）; and Director, Human Resource Strategy Center for Global Health. He is aveteran public health specialist for over 40 years, who started his career at the Ministry of Health, Labour andWelfare in Japan. He worked extensively in health policy, public health, international health, and healthscience and technology. His national career includes serving as Director-General of Health and Welfare Services
in Hiroshima Prefecture, where he was in charge of integrating health and welfare services in preparation for
the arrival of a rapidly ageing society.
Regarding international career, he served the WHO Headquarters twice. From March 2007 to May 2015, heserved as Assistant Director-General of WHO, leading the largest technical cluster of HIV/AIDS, Tuberculosis,
Malaria and Neglected Tropical Diseases. Dr. Nakatani received his MD from Keio University School of
Medicine, MHPEd from the University of New South Wales, and a Ph.D. from Keio University.

Lecturesummary

The first session, "WHO and its role in global health governance, " aims to achieve the following objectives：(1) to understand global health's complex architecture with special attention to UN agencies' roles, particularly
WHO; (2) to understand the governance and operation style in different organizations, i.e., intergovernmentalorganizations and partnerships; (3) to gain practical skills to be an influential contributor in governing bodymeetings. This starts by analyzing the massive volume of background paper in a relatively short time.
Participants are invited to visit the WHO governing bodies website (Ref.2) before coming to class. This
experience will make participants miserable initially, but after the session, everyone will feel encouraged.
The following sessions, Mockup interventions, aim at being an influential contributor in the official meeting.
The four-step approach will be practiced; (1) Reviewing the background paper; (2) Digesting the instruction
given by the Government after inter-ministerial discussion; (3) Drafting intervention and making actualintervention to fellow participants. At each step, there are seasoned hints and skills. They are shared, andMock interviews enable participants to improve each one's intervention by practice and constructive
comments by facilitators and among fellow participants.

Reading list

1.
2.
3.
4.

WHO: Basic Document Forty-ninth Edition,2020 https://apps.who.int/gb/bd/pdf_files/BD_49th-en.pdf
WHO: Governing Bodies website https://apps.who.int/gb/gov/
United Nations: Model United Nations https://www.un.org/en/mun/model-un-guide
グローバル・クラスルーム日本委員会： 模擬国連マニュアル http://jcgc.accu.or.jp/manual.pdf

Global Health Diplomacy Workshop2022

Resource person profile

Dr. Haruka Sakamoto

15

Title

Dr.

Affiliation

Tokyo Women’s Medical University

ProfileHaruka SAKAMOTO, MD MPH, PhD, is a primary care physician and associate professor at the Section of
Global Health, Department of Hygiene and Public Health, Tokyo Women’s Medical University. She got her
M.D from Sapporo Medical University and worked as a physician at St Luke’s International Hospital in Tokyo
for several years. She then got a scholarship from the World Bank and got her MPH at the Harvard T.H Chan
School of Public Health. From 2011-2013 and 2016, she worked at the international cooperation department,
Ministry of Health, Labour and Welfare of Japan, where she was deeply involved in health policy activities inJapan. As part of the work, she participated in WHO meetings, G7 meetings, and bilateral cooperation
activities through JICA (Japan International Cooperation Agency). She got PhD from University of Tokyo in
2021, and she’s also currently working at Gates Foundation Tokyo Office, and World Health Organization as aconsultant, and Department of Global Health Policy, Graduate School of Medicine, the University of Tokyo as
a project researcher. Her current research focuses on health system strengthening, health care financing, andpolitics in global health.

Lecturesummary

Many people are unfamiliar with an intervention at international conferences and have no idea what is the"format" of an intervention. In this lecture, I will show you what to include in your intervention, starting withthe format of interventions you should make at international conferences (mainly at the WHO meetings). On
the other hand, I will tell you about some bad things you better not to say (don't).

Global Health Diplomacy Workshop2022